H.Amdt. 23
U.S. House of Representatives•Amends H.R. 2483
Summary
Rep. Robert Bresnahan (R-PA) offered H.Amdt. 23 to H.R. 2483, the SUPPORT for Patients and Communities Reauthorization Act of 2025, on Jun 4, 2025.
On Jun 4, 2025: On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.
An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.
Record
H.Amdt. 23 has 0 co-sponsors, 4 actions and 0 text versions on the record.
Text
No text on file for H.Amdt. 23 yet; read it at congress.gov.
Sponsors
Robert Bresnahan offered H.Amdt. 23.
Actions
H.Amdt. 23 has 4 actions on the record.
| Chamber | Action | |||
|---|---|---|---|---|
Jun 4, 202515:08 | Library of Congress | On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote. | ||
Jun 4, 202515:08 | Library of Congress | House amendment agreed to: On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote. | ||
Jun 4, 202515:05 | Library of Congress | House Amendment Offered | ||
Jun 4, 202515:05 | Library of Congress |
Source: congress.gov